Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Single-Blind Multi-Centre Evaluation of the Safety and Performance of an Injection of Hydrogel OA 2% in Subjects With Knee Osteoarthritis

NCT06839222 is registered in ClinicalTrials.gov with Allegro NV/SA as lead sponsor.

NCT NCT06839222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06839222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Single-Blind Multi-Centre Evaluation of the Safety and Performance of an Injection of Hydrogel OA 2% in Subjects With Knee Osteoarthritis
Lead sponsor
Allegro NV/SA
Phase
Not applicable
Overall status
Withdrawn
Start date
May 31, 2025
Completion date
November 30, 2026
Enrollment
0 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis (knee oa)